AU2456701A - Pharmaceutical and veterinary uses of endothelin antagonists - Google Patents

Pharmaceutical and veterinary uses of endothelin antagonists

Info

Publication number: AU2456701A
Authority: AU; Australia
Prior art keywords: pharmaceutical; endothelin antagonists; veterinary uses; veterinary; endothelin
Prior art date: 1999-12-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU24567/01A

Inventor

Thomas A. Brock

Patrick R. Ward

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Encysive Pharmaceuticals Inc

Original Assignee

Texas Biotechnology Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-31

Filing date

2000-12-27

Publication date

2001-07-16

2000-12-27 Application filed by Texas Biotechnology Corp filed Critical Texas Biotechnology Corp

2001-07-16 Publication of AU2456701A publication Critical patent/AU2456701A/en

Status Abandoned legal-status Critical Current

Links

102000002045 Endothelin Human genes 0.000 title 1
108050009340 Endothelin Proteins 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Cardiology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Heart & Thoracic Surgery (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU24567/01A 1999-12-31 2000-12-27 Pharmaceutical and veterinary uses of endothelin antagonists Abandoned AU2456701A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US17412599P	1999-12-31	1999-12-31
US60174125		1999-12-31
PCT/US2000/035280 WO2001049289A1 (en)	1999-12-31	2000-12-27	Pharmaceutical and veterinary uses of endothelin antagonists

Publications (1)

Publication Number	Publication Date
AU2456701A true AU2456701A (en)	2001-07-16

Family

ID=22634931

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU24567/01A Abandoned AU2456701A (en)	1999-12-31	2000-12-27	Pharmaceutical and veterinary uses of endothelin antagonists

Country Status (2)

Country	Link
AU (1)	AU2456701A (en)
WO (1)	WO2001049289A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4448902B2 (en)	2001-06-08	2010-04-14	株式会社医薬分子設計研究所	Sulfonamide derivatives
EP2415760A3 (en) *	2003-02-20	2012-02-22	Encysive Pharmaceuticals, Inc.	CCR-9 antagonists
US7288538B2 (en)	2003-02-20	2007-10-30	Encysive Pharmaceuticals, Inc.	Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
DE102004005787A1 (en) *	2004-02-06	2005-08-25	Bayer Cropscience Ag	carboxamides
WO2008019072A2 (en) *	2006-08-04	2008-02-14	Encysive Pharmaceuticals, Inc.	Polymorphs of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)-amino]sulfonyl}-2-thiophene-carboxamide
CL2008000835A1 (en)	2007-03-23	2008-10-03	Icagen Inc Pfizer Ltd	COMPOUNDS DERIVED FROM SULFONAMIDS, INHIBITORS OF THE CALCIUM CHANNELS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF PAIN, IRRITABLE INTESTINE SYNDROME, CROHN DISEASE, TAQUIARRITM
WO2012064774A1 (en) *	2010-11-10	2012-05-18	The Board Of Trustees Of The Leland Stanford Junior University	An ire1alpha endonuclease specific inhibitor with cytotoxic activity
TW201512171A (en)	2013-04-19	2015-04-01	Pfizer Ltd	Chemical compounds
GB201810092D0 (en)	2018-06-20	2018-08-08	Ctxt Pty Ltd	Compounds
GB201810581D0 (en)	2018-06-28	2018-08-15	Ctxt Pty Ltd	Compounds
AU2020296361A1 (en)	2019-06-18	2022-01-06	Ctxt Pty Ltd	Benzisoxazole sulfonamide derivatives
JP2023523545A (en)	2020-04-17	2023-06-06	エサイエントファーマシューティカルズ，インコーポレイティド	Modulators of Mas-related G protein receptor X4, related products and methods of use thereof
CN113607525B (en) *	2021-08-09	2024-06-14	安徽信灵检验医学科技股份有限公司	Vacuum blood collection tube additive for blood digestion and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2281207A (en) *	1993-08-28	1995-03-01	Univ Sheffield	Treatment of laminitis with l-arginine
AU7655494A (en) *	1993-08-28	1995-03-22	University Of Sheffield, The	Treatment of laminitis
GB2292520B (en) *	1994-08-25	1998-09-02	Univ Sheffield	Transdermal dressings for animals
NZ306734A (en) *	1995-04-04	2000-01-28	Texas Biotechnology Corp
US5804585A (en) *	1996-04-15	1998-09-08	Texas Biotechnology Corporation	Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
NZ336898A (en) *	1997-04-28	2001-10-26	Texas Biotechnology Corp	Sulfonamides for treatment of endothelin-mediated disorders
CN1149196C (en) *	1998-07-06	2004-05-12	布里斯托尔-迈尔斯斯奎布公司	Biphenylsulfonamides as dual antagonists of angiotensin and endothelin receptors

2000
- 2000-12-27 WO PCT/US2000/035280 patent/WO2001049289A1/en not_active Ceased
- 2000-12-27 AU AU24567/01A patent/AU2456701A/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2001049289A1 (en)	2001-07-12

Publication	Publication Date	Title
AU5440901A (en)	2001-07-03	Cosmetic and/or pharmaceutical preparations
AU2319100A (en)	2000-08-18	Amide derivatives and drug compositions
AU2223201A (en)	2001-07-09	Quinoline and quinazoline derivatives and drugs containing the same
AUPQ969800A0 (en)	2000-09-21	Pyrazolopyridine compound and pharmaceutical use thereof
AU3620600A (en)	2000-09-28	Skin-marking devices and their use
HUP0200831A3 (en)	2004-04-28	Novel pharmaceutical composition containing amoxycillin and its use
AU5326100A (en)	2000-12-28	Pharmaceutical compositions and methods for use
AU2002354476A1 (en)	2003-06-30	Pyrazolopyridine derivatives and medicinal use thereof
PL342500A1 (en)	2001-06-04	Derivatives of pyrolydin-3-carboxylic acid and their application as endothelin antagonists
AU1164601A (en)	2001-06-06	Therapeutic use and formulation
AU2456701A (en)	2001-07-16	Pharmaceutical and veterinary uses of endothelin antagonists
HUP0203121A3 (en)	2004-01-28	Pharmaceutical composition containing substituted benzimidazoles and its use
AU2001288061A1 (en)	2002-04-15	Drug resistance-associated gene and use thereof
AU2002308891A1 (en)	2003-05-08	Novel heterocyclic derivatives and medicinal use thereof
AU2438400A (en)	2000-08-18	Cosmetic and/or pharmaceutical preparations
AU1730201A (en)	2001-06-12	Proteoglycans and pharmaceutical compositions comprising them
AU7271600A (en)	2001-03-05	Quinazolinone and azaquinazolinone derivatives
AU4293800A (en)	2000-11-14	Cosmetic and/or pharmaceutical preparations
AU1053501A (en)	2001-05-14	Polyazanaphthalene compound and medicinal use thereof
AUPQ462299A0 (en)	2000-01-13	Pyrazolopyridine compound and pharmaceutical use thereof
AU6179600A (en)	2001-04-10	Peptides and pharmaceutical compositions comprising same
AUPP672198A0 (en)	1998-11-19	Pyrazolopyridine compound and pharmaceutical use thereof
AU4543500A (en)	2000-10-23	Pharmaceutical compositions and uses
AU6866700A (en)	2001-03-26	Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof
HUP0200812A3 (en)	2003-07-28	Vitamin d analogues and their pharmaceutical use

Legal Events

Date	Code	Title	Description
2002-08-29	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase